Crsp stock forecast 2025.

Among the leaders in the nascent CRISPR space are biotech stocks like CRISPR Therapeutics, (CRSP 2.88%) Editas Medicine, and Intellia Therapeutics. These companies have pipelines that are jam ...See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.20 stocks of aerospace and defense companies expected to grow sales most quickly through 2025 Sep. 16, 2023 at 9:07 a.m ...Oct 27, 2023 · Unraveling CRISPR Therapeutics (CRSP) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing CRISPR Therapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.

CRISPR Therapeutics AG (NASDAQ:CRSP) CRISPR Therapeutics AG. 68.97. Delayed Data. As of 3:59pm ET. -1.69 / -2.39%. Today’s Change. 37.55. Today ||| 52-Week Range.AbCellera Biologics Inc () Stock Market info Recommendations: Buy or sell AbCellera Biologics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the AbCellera Biologics share forecasts, stock quote and buy / sell signals below.According to present data AbCellera Biologics's ABCL shares and potentially its …

In 2025, PLTR is forecast to generate $7,065,779,111,474 in revenue, with the lowest revenue forecast at $6,874,690,253,056 and the highest revenue forecast at $7,496,779,501,781. ... with the highest PLTR stock price forecast at $25.00 and the lowest PLTR stock price forecast at $5.00.On average, Wall Street analysts predict. that …

With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics ( CRSP -6.39%) and Bluebird Bio ( BLUE -4.44%). These ...Nov 1, 2023 · Forecast for December 2025. It is predicted that the price of one CRISPR Therapeutics share in will be in the range of $52.12 to $60.68. The width of this range will be $8.56 (14.10%). The average price is $54.03, which is $0.17 less than the average price of the previous month. The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.That success has led to dramatic price increases for CRSP stock since going public in 2016. Shares flirted with the $200 level in 2021 during the most recent market peak. They currently trade for ...

Get the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

The average CRISPR Therapeutics AG stock forecast 2024 represents a -25.46% decrease from the last price of $68.6500015258789. For CRISPR Therapeutics AG stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CRISPR Therapeutics AG stock forecast of $49.41, a high forecast of $51.16, and a low forecast of $46.49. Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions.Target values for the price of one Clover Health Investments share for Nov 2025. The weighted average target price per Clover Health Investments share in Nov 2025 is: 2.33. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.238% volatility is expected. Pessimistic target level: 2.00.Price Prediction CRISPR Therapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Wall Street Stock Market & Finance report, prediction for the future: You'll find the AbCellera Biologics share forecasts, stock quote and buy / sell signals below. According to present data AbCellera Biologics's ABCL shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Q1 2024 EPS Estimate Trends. Current. -$1.61. 1 Month Ago. -$1.85. 3 Months Ago. -$1.85. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst ...

Mar 9, 2021 · CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price. Salesforce Inc () Stock Market info Recommendations: Buy or sell Salesforce stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Salesforce share forecasts, stock quote and buy / sell signals below.According to present data Salesforce's CRM shares and potentially its market environment have been in a bullish …January 2025. January 2026. December 2023. Calls. Expires Dec 1, 2023 ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq ...Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 …Financial traders can chatter all they want about Apple's earnings miss, but there's data indicating strong upside potential for AAPL stock. A rare earnings miss for Apple doesn't mean you should dump AAPL stock Source: Vytautas Kielaitis /...CRSP stock has fallen 16% over the last month (twenty-one trading days), after a rise in bond yields, along with rising concerns over the spread of a newer Covid-19 variant - Omicron - led to a ...CRISPR Therapeutics (CRSP) stock forecast for 2025. Forecast tables and graphs. All stock predictions Overall outlook for CRISPR Therapeutics stock 2023 …

The average price target for CrowdStrike Holdings is $203.15. This is based on 34 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $240.00 ,the lowest forecast is $167.00. The average price target represents -2.79% Decrease from the current price of $208.98.CRISPR Therapeutics AG (NASDAQ:CRSP) CRISPR Therapeutics AG. 68.97. Delayed Data. As of 3:59pm ET. -1.69 / -2.39%. Today’s Change. 37.55. Today ||| 52-Week Range.

Get the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Analysts expect revenue growth at 8% this year and further acceleration above double digits through 2025. EPS growth is also at ~25 for 2024 and 2025, respectively — very attractive at these levels.CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 28, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics …CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict …The average CRISPR Therapeutics AG stock forecast 2024 represents a -25.46% decrease from the last price of $68.6500015258789. For CRISPR Therapeutics AG stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CRISPR Therapeutics AG stock forecast of $49.41, a high forecast of $51.16, and a low forecast of $46.49.CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97.

Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for DNA stock stock is $3.25, which predicts an increase of 122.60%. The lowest target is $1.25 and the highest is $6.00. On average, analysts rate DNA stock stock as a hold.

Apr 13, 2022 · Among the leaders in the nascent CRISPR space are biotech stocks like CRISPR Therapeutics, (CRSP 2.88%) Editas Medicine, and Intellia Therapeutics. These companies have pipelines that are jam ...

1.76%. $20.2M. Plandai Biotechnology Inc. -20.00%. $1.94M. CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CRSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.CRSP stock extended its rally from levels of around $107 in mid-November 2020 to $161 currently. Also, the stock has rallied a stellar 5x from levels of $34 in late March 2020 – when markets ...Find real-time SHEL - Shell PLC stock quotes, company profile, news and forecasts from CNN Business.Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary.The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than …In the last quarter, shares of CRISPR Therapeutics CRSP have gained 24.1% against the industry ’s 3.4% fall. The steep rise in the stock price can be associated with the completion of the ...How much will CRISPR Therapeutics cost in 2021 – 2025? Forecast: (CRSP) for today November 26 & Weekly Forecast from 19 November to 2 December Price Prediction …

Since bonds and stocks compete for investors' dollars, a higher yield typically needs to be paid to the stock investor for the extra risk being assumed vs. the virtual risk-free investment offered ...Oct 15, 2020 · Roku Inc - Class A (ROKU) stock price prediction is 205.24788816489 USD. The Roku Inc - Class A stock forecast is 205.24788816489 USD for 2024 November 30, Saturday; and 1033.706 USD for 2028 November 30, Thursday with technical analysis. CRSP - CRISPR Therapeutics AG Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Instagram:https://instagram. nasdaq tsllnasdaq pebowhat quarters are collectiblebest health insurance companies in ga Ford stock (F) has risen by more than 40 percent year-to-date, in part due to its strong EV potential. What's Ford's stock forecast for 2025? Growth stocks, including pure-play EV (electric ... best forex trading bookstop ten forex brokers Find real-time CRSR - Corsair Gaming Inc stock quotes, company profile, news and forecasts from CNN Business. top mortgage lenders in tennessee That has helped lift growth stocks as investors prepare their portfolios for better times. And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced ...The Trimble stock forecast is 92.58442711926 USD for 2024 November 09, Saturday; and 383.563 USD for 2028 November 09, Thursday with technical analysis. Trimble (TRMB) stock price prediction is 92.58442711926 USD.Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52.